Loading…
Eiko Lifesciences (BSE 540204)₹49.86−1.64%Specialty Chemicals
At the end of the Jun 2026 quarter, Eiko Lifesciences' shareholders were: promoters 39.94%, public 60.06%. Promoter holding is unchanged on the quarter. It had 3,020 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 24.26% | 24.26% | 24.26% | 24.43% | 24.43% | 31.30% | 36.26% | 36.77% | 37.20% | 37.20% | 39.94% | 39.94% |
| Public | 75.74% | 75.74% | 75.74% | 75.57% | 75.57% | 68.70% | 63.74% | 63.23% | 62.80% | 62.80% | 60.06% | 60.06% |
| Number of shareholders | 2,723 | 2,638 | 2,914 | 2,939 | 3,142 | 3,458 | 3,338 | 3,324 | 3,152 | 3,093 | 2,970 | 3,020 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Lenus Finvest Private Limited | Promoter | 17.72% | 0.00 |
| Laxmikant Kabra (Huf) | Promoter | 9.94% | 0.00 |
| 2B Black Bio Llp | Public | 9.65% | +0.04 |
| Bhavesh Dhirajlal Tanna | Promoter | 5.85% | 0.00 |
| Siddhant Laxmikant Kabra | Promoter | 5.59% | 0.00 |
| Ashika Global Finance Private Limited | Public | 4.20% | +0.06 |
| Ashok Vishwanath Hiremath | Public | 3.73% | 0.00 |
| Sushila Paraskumar Daga | Public | 2.80% | +1.13 |
| Sivanesan Sellappan | Public | 2.00% | 0.00 |
| Joyanta Kumar Jana | Public | 1.98% | 0.00 |
| Parshva Kumar Daga | Public | 1.69% | +0.03 |
| Bhavinkumar Vinaychand Shah | Public | 1.36% | 0.00 |
| Kaushik Daga | Public | 1.10% | −1.11 |
| Laxmikant Ramprasad Kabra | Promoter | 0.81% | 0.00 |
Promoters held 39.94% of Eiko Lifesciences at the end of the Jun 2026 quarter, up 3.17 percentage points from 36.77% a year earlier.
Eiko Lifesciences had 3,020 shareholders at the end of the Jun 2026 quarter, against 3,324 a year earlier.
2B Black Bio Llp (Public) held 9.65% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.